Upgraded heart failure therapy leads to an improved outcome of dilated cardiomyopathy in infants and toddlers.

Objective: Dilated cardiomyopathy is a leading cause of cardiac death in children. Approximately 30% of children die or need cardiac transplantation in the first year after establishing the diagnosis. New strategies are needed to improve the outcome in this high-risk patient population.